AI assistant
Protagonist Therapeutics, Inc — Director's Dealing 2016
Aug 11, 2016
31163_dirs_2016-08-10_15b2bcec-ef26-4d31-a82c-aaceb8753a82.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Protagonist Therapeutics, Inc (PTGX)
CIK: 0001377121
Period of Report: 2016-08-10
Reporting Person: HODDER WILLIAM A (Sr. VP - Corporate Development)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 7943 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Employee Stock Option (right to buy) | $1.89 | 2025-03-26 | Common Stock (18052) | Direct | |
| Employee Stock Option (right to buy) | $1.16 | 2025-10-28 | Common Stock (14087) | Direct | |
| Employee Stock Option (right to buy) | $4.21 | 2026-04-29 | Common Stock (21449) | Direct |
Footnotes
F1: 1/4th of the shares subject to the option shall vest on the one year anniversary of the vesting commencement date, and 1/36th of the remaining shares subject to the option shall vest on the last day of each month following the first anniversary of the vesting commencement date, subject to the Reporting Person continuing to be a service provider of the Issuer through each such date.
F2: 1/48th of the shares subject to the option shall vest on the last day of each month following the vesting commencement date, subject to the Reporting Person continuing to be a service provider of the Issuer through each such date.